Clinical Trial Update: CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating CD7 CAR-T cell therapy sequentially with allogeneic HSCT for bone marrow failure syndrome, a non-malignant blood and immune system dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure Syndrome

Drugs mentioned

• CD7 CAR-T cell (CD7-targeted CAR-T cell)

Snippet

Sponsor: Zhejiang University | Conditions: Bone Marrow Failure Syndrome | EARLY_Phase 1 | Status: RECRUITING